$4.77 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 127 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 43.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NUVALENT INC | $368,253,000 | -15.6% | 19,341,024 | 0.0% | 7.72% | -9.3% | ||
| VTRS | Buy | VIATRIS INC | $281,072,000 | +10.2% | 20,774,000 | +10.4% | 5.90% | +18.4% |
| AHCO | Buy | ADAPTHEALTH CORP | $250,114,000 | +32.5% | 10,225,445 | +26.2% | 5.25% | +42.4% |
| Buy | GLAUKOS CORPnote 2.750% 6/1 | $242,436,000 | +87.0% | 204,700,000 | +89.5% | 5.08% | +101.0% | |
| INVITAE CORPnote 2.000% 9/0 | $153,337,000 | -23.2% | 163,385,000 | 0.0% | 3.22% | -17.5% | ||
| AERIE PHARMACEUTICALS INCnote 1.500%10/0 | $130,154,000 | -9.5% | 157,390,000 | 0.0% | 2.73% | -2.7% | ||
| CMAX | CAREMAX INC | $128,861,000 | -20.5% | 16,778,750 | 0.0% | 2.70% | -14.5% | |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $117,360,000 | +7.1% | 1,377,945 | +20.6% | 2.46% | +15.2% |
| ENVISTA HOLDINGS CORPORATIONnote 2.375% 6/0 | $116,547,000 | +6.7% | 52,500,000 | 0.0% | 2.44% | +14.7% | ||
| NATERA INCnote 2.250% 5/0 | $115,754,000 | -14.4% | 45,000,000 | 0.0% | 2.43% | -8.0% | ||
| OMIC | SINGULAR GENOMICS SYSTEMS IN | $105,335,000 | +3.3% | 9,112,019 | 0.0% | 2.21% | +11.0% | |
| NUVASIVE INCnote 1.000% 6/0 | $96,617,000 | -2.2% | 96,966,000 | 0.0% | 2.03% | +5.1% | ||
| PACIRA BIOSCIENCES INCnote 0.750% 8/0 | $90,486,000 | +3.1% | 81,600,000 | 0.0% | 1.90% | +10.9% | ||
| CNC | CENTENE CORP DEL | $82,713,000 | +32.2% | 1,003,800 | 0.0% | 1.74% | +42.1% | |
| Buy | TABULA RASA HEALTHCARE INCnote 1.750% 2/1 | $80,473,000 | +114.9% | 97,816,000 | +117.4% | 1.69% | +130.9% | |
| ISEE | Sell | IVERIC BIO INC | $79,606,000 | +0.8% | 4,761,138 | -2.1% | 1.67% | +8.3% |
| ORGO | Buy | ORGANOGENESIS HLDGS INC | $78,142,000 | -26.5% | 8,456,876 | +13.3% | 1.64% | -21.0% |
| INSULET CORPnote 0.375% 9/0 | $76,356,000 | -5.0% | 57,581,000 | 0.0% | 1.60% | +2.1% | ||
| LUNG | Buy | PULMONX CORP | $75,905,000 | +3.9% | 2,366,867 | +16.6% | 1.59% | +11.7% |
| Buy | NUVASIVE INCnote 0.375% 3/1 | $74,729,000 | +38.1% | 77,859,000 | +39.5% | 1.57% | +48.4% | |
| Buy | NEVRO CORPnote 2.750% 4/0 | $68,194,000 | +95.5% | 61,000,000 | +134.6% | 1.43% | +110.0% | |
| SILK | Buy | SILK RD MED INC | $64,647,000 | +18.6% | 1,517,181 | +53.2% | 1.36% | +27.4% |
| LRMR | LARIMAR THERAPEUTICS INC | $62,908,000 | -6.4% | 5,830,249 | 0.0% | 1.32% | +0.5% | |
| Buy | SEMA4 HOLDINGS CORP | $62,292,000 | -40.7% | 13,966,824 | +0.9% | 1.31% | -36.3% | |
| EWTX | EDGEWISE THERAPEUTICS INC | $60,098,000 | -8.0% | 3,933,137 | 0.0% | 1.26% | -1.0% | |
| BRIDGEBIO PHARMA INCnote 2.500% 3/1 | $58,890,000 | -46.7% | 80,000,000 | 0.0% | 1.24% | -42.7% | ||
| DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $54,521,000 | +96.9% | 5,580,456 | +584.7% | 1.14% | +111.9% |
| INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0 | $54,417,000 | +4.4% | 57,791,000 | 0.0% | 1.14% | +12.2% | ||
| APR | Buy | APRIA INC | $53,979,000 | +2.5% | 1,655,795 | +16.8% | 1.13% | +10.1% |
| MIRM | MIRUM PHARMACEUTICALS INC | $52,362,000 | -19.9% | 3,282,912 | 0.0% | 1.10% | -13.9% | |
| GKOS | Buy | GLAUKOS CORP | $51,613,000 | +73.1% | 1,161,414 | +87.6% | 1.08% | +86.1% |
| INSMED INCnote 1.750% 1/1 | $51,321,000 | -0.8% | 50,000,000 | 0.0% | 1.08% | +6.6% | ||
| KURA | Buy | KURA ONCOLOGY INC | $49,193,000 | +13.4% | 3,513,756 | +51.8% | 1.03% | +22.0% |
| APELLIS PHARMACEUTICALS INCnote 3.500% 9/1 | $43,542,000 | +22.7% | 28,825,000 | 0.0% | 0.91% | +31.7% | ||
| MOH | Sell | MOLINA HEALTHCARE INC | $42,937,000 | -31.7% | 134,989 | -41.8% | 0.90% | -26.6% |
| ATEC | ALPHATEC HLDGS INC | $41,089,000 | -6.2% | 3,594,829 | 0.0% | 0.86% | +0.8% | |
| PTGX | Sell | PROTAGONIST THERAPEUTICS INC | $40,115,000 | +62.4% | 1,172,943 | -15.9% | 0.84% | +74.5% |
| DAWN | Buy | DAY ONE BIOPHARMACEUTICALS I | $37,113,000 | -8.6% | 2,202,533 | +28.7% | 0.78% | -1.8% |
| CYTK | Sell | CYTOKINETICS INC | $36,874,000 | -32.9% | 809,000 | -47.4% | 0.77% | -27.9% |
| PCRX | Sell | PACIRA BIOSCIENCES INC | $35,882,000 | -33.8% | 596,338 | -38.3% | 0.75% | -28.8% |
| NOVAVAX INCnote 3.750% 2/0 | $34,424,000 | -20.0% | 25,000,000 | 0.0% | 0.72% | -14.0% | ||
| New | XILIO THERAPEUTICS INC | $33,739,000 | – | 2,154,061 | +100.0% | 0.71% | – | |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $32,959,000 | -2.9% | 4,695,020 | +57.7% | 0.69% | +4.4% |
| New | THE ONCOLOGY INSTITUTE INC | $32,137,000 | – | 3,296,107 | +100.0% | 0.67% | – | |
| NUVB | NUVATION BIO INC | $30,406,000 | -14.5% | 3,577,233 | 0.0% | 0.64% | -8.1% | |
| SWTX | Sell | SPRINGWORKS THERAPEUTICS INC | $28,015,000 | -13.5% | 452,000 | -11.5% | 0.59% | -7.0% |
| ESPR | New | ESPERION THERAPEUTICS INC NE | $25,000,000 | – | 5,000,000 | +100.0% | 0.52% | – |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS INC | $23,353,000 | +592.6% | 1,686,140 | +618.6% | 0.49% | +642.4% |
| VIVO | Sell | MERIDIAN BIOSCIENCE INC | $22,952,000 | -42.2% | 1,125,083 | -45.5% | 0.48% | -37.9% |
| FIGS | New | FIGS INCcl a | $22,867,000 | – | 829,707 | +100.0% | 0.48% | – |
| PHVS | Sell | PHARVARIS N V | $22,755,000 | -20.2% | 1,581,331 | -1.7% | 0.48% | -14.4% |
| RVMD | Sell | REVOLUTION MEDICINES INC | $22,441,000 | -47.9% | 891,587 | -43.1% | 0.47% | -44.0% |
| BKD | Sell | BROOKDALE SR LIVING INC | $22,058,000 | -33.3% | 4,274,808 | -18.6% | 0.46% | -28.3% |
| HEALTH CATALYST INCnote 2.500% 4/1 | $21,789,000 | -17.1% | 15,000,000 | 0.0% | 0.46% | -10.9% | ||
| ALEC | ALECTOR INC | $21,790,000 | -9.5% | 1,055,192 | 0.0% | 0.46% | -2.8% | |
| XERIS BIOPHARMA HOLDINGS INCnote 5.000% 7/1 | $21,577,000 | +14.4% | 18,000,000 | 0.0% | 0.45% | +23.1% | ||
| BLU | New | BELLUS HEALTH INC NEW | $19,714,000 | – | 2,449,000 | +100.0% | 0.41% | – |
| PROF | Buy | PROFOUND MED CORP | $19,246,000 | +1.3% | 1,713,797 | +32.1% | 0.40% | +8.9% |
| RYTM | Sell | RHYTHM PHARMACEUTICALS INC | $18,637,000 | -28.3% | 1,867,467 | -6.1% | 0.39% | -22.9% |
| OM | OUTSET MED INC | $18,465,000 | -6.8% | 400,622 | 0.0% | 0.39% | 0.0% | |
| NVRO | New | NEVRO CORP | $17,511,000 | – | 216,000 | +100.0% | 0.37% | – |
| KNTE | Sell | KINNATE BIOPHARMA INC | $17,464,000 | -26.2% | 985,568 | -4.2% | 0.37% | -20.8% |
| BBIO | New | BRIDGEBIO PHARMA INCcall | $16,680,000 | – | 1,000,000 | +100.0% | 0.35% | – |
| TERN | TERNS PHARMACEUTICALS INC | $16,586,000 | -32.1% | 2,345,959 | 0.0% | 0.35% | -27.0% | |
| ONCR | ONCORUS INC | $16,595,000 | -43.6% | 3,148,977 | 0.0% | 0.35% | -39.4% | |
| APLS | New | APELLIS PHARMACEUTICALS INC | $16,227,000 | – | 343,213 | +100.0% | 0.34% | – |
| INZY | INOZYME PHARMA INC | $15,991,000 | -41.2% | 2,344,786 | 0.0% | 0.34% | -36.8% | |
| DA32 LIFE SCNCE TEC ACQSTN C | $15,696,000 | -0.2% | 1,600,000 | 0.0% | 0.33% | +7.2% | ||
| KALV | Sell | KALVISTA PHARMACEUTICALS INC | $15,547,000 | -58.8% | 1,175,131 | -45.7% | 0.33% | -55.8% |
| PTC THERAPEUTICS INCnote 3.000% 8/1 | $15,326,000 | +1.8% | 14,527,000 | 0.0% | 0.32% | +9.2% | ||
| APEN | New | APOLLO ENDOSURGERY INC | $14,753,000 | – | 1,750,000 | +100.0% | 0.31% | – |
| VINC | VINCERX PHARMA INC | $14,055,000 | -37.0% | 1,379,310 | 0.0% | 0.30% | -32.2% | |
| MRUS | New | MERUS N V | $13,897,000 | – | 437,000 | +100.0% | 0.29% | – |
| COGT | COGENT BIOSCIENCES INC | $13,737,000 | +2.0% | 1,601,000 | 0.0% | 0.29% | +9.5% | |
| MRTX | New | MIRATI THERAPEUTICS INC | $12,909,000 | – | 88,000 | +100.0% | 0.27% | – |
| SRPT | New | SAREPTA THERAPEUTICS INC | $12,697,000 | – | 141,000 | +100.0% | 0.27% | – |
| PMVP | Sell | PMV PHARMACEUTICALS INC | $12,058,000 | -49.7% | 522,000 | -35.1% | 0.25% | -45.9% |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $11,782,000 | -38.2% | 110,000 | -40.7% | 0.25% | -33.6% |
| HOWL | Sell | WEREWOLF THERAPEUTICS INC | $11,411,000 | -62.1% | 958,125 | -45.3% | 0.24% | -59.3% |
| QSI | QUANTUM SI INC | $11,018,000 | -5.6% | 1,400,000 | 0.0% | 0.23% | +1.3% | |
| New | LIANBIOsponsored ads | $10,982,000 | – | 1,782,747 | +100.0% | 0.23% | – | |
| Buy | NYXOAH S A | $10,471,000 | +19.0% | 455,262 | +51.4% | 0.22% | +27.9% | |
| CGEM | Sell | CULLINAN ONCOLOGY INC | $10,364,000 | -56.0% | 671,690 | -35.7% | 0.22% | -52.8% |
| MTAC | MEDTECH ACQUISITION CORP | $9,880,000 | -0.5% | 999,999 | 0.0% | 0.21% | +6.7% | |
| SRSA | New | SARISSA CAPITAL ACQUISITN COcl a | $9,790,000 | – | 999,999 | +100.0% | 0.20% | – |
| EUCR | New | EUCRATES BIOMEDICAL ACQU COR | $9,760,000 | – | 999,999 | +100.0% | 0.20% | – |
| REVH | REVOLUTION HEALTHCAR AQ CORP | $9,740,000 | +0.3% | 1,000,000 | 0.0% | 0.20% | +7.4% | |
| SNRH | SENIOR CONNECT ACQUISITN COR | $9,740,000 | -0.3% | 1,000,000 | 0.0% | 0.20% | +6.8% | |
| GRAY | GRAYBUG VISION INC | $9,666,000 | -44.9% | 5,281,713 | 0.0% | 0.20% | -40.6% | |
| ORTX | ORCHARD THERAPEUTICS PLCads | $9,173,000 | -42.6% | 6,949,416 | 0.0% | 0.19% | -38.5% | |
| AFIB | ACUTUS MED INC | $9,031,000 | -61.4% | 2,648,386 | 0.0% | 0.19% | -58.6% | |
| New | WEAVE COMMUNICATIONS INC | $8,418,000 | – | 554,519 | +100.0% | 0.18% | – | |
| New | GUARDANT HEALTH INCnote 11/1 | $8,053,000 | – | 8,000,000 | +100.0% | 0.17% | – | |
| PRVA | PRIVIA HEALTH GROUP INC | $7,761,000 | +9.8% | 300,000 | 0.0% | 0.16% | +18.1% | |
| TMPM | New | TURMERIC ACQUISITION CORPcl a | $7,365,000 | – | 750,000 | +100.0% | 0.15% | – |
| New | HYPERFINE INC | $7,250,000 | – | 1,000,000 | +100.0% | 0.15% | – | |
| IGNY | IGNYTE ACQUISITION CORP | $7,062,000 | -0.5% | 725,000 | 0.0% | 0.15% | +6.5% | |
| DEFINITIVE HEALTHCARE CORP | $6,833,000 | -36.2% | 250,000 | 0.0% | 0.14% | -31.6% | ||
| ANNX | ANNEXON INC | $6,709,000 | -38.3% | 583,913 | 0.0% | 0.14% | -33.5% | |
| New | BENEFITFOCUS INCnote 1.250%12/1 | $6,229,000 | – | 6,500,000 | +100.0% | 0.13% | – | |
| AMWL | AMERICAN WELL CORPcl a | $5,986,000 | -33.7% | 991,115 | 0.0% | 0.13% | -28.4% | |
| BCAB | Sell | BIOATLA INC | $5,673,000 | -58.5% | 289,002 | -37.8% | 0.12% | -55.4% |
| OHPA | ORION ACQUISITION CORP | $4,890,000 | +0.8% | 500,000 | 0.0% | 0.10% | +8.4% | |
| DCTH | DELCATH SYS INC | $3,875,000 | -25.8% | 500,000 | 0.0% | 0.08% | -20.6% | |
| New | PYXIS ONCOLOGY INC | $3,420,000 | – | 311,754 | +100.0% | 0.07% | – | |
| NEOGENOMICS INCnote 0.250% 1/1 | $2,132,000 | -15.2% | 2,500,000 | 0.0% | 0.04% | -8.2% | ||
| New | ROIVANT SCIENCES LTD*w exp 09/30/202 | $2,047,000 | – | 1,000,000 | +100.0% | 0.04% | – | |
| GKOS | New | GLAUKOS CORPcall | $2,009,000 | – | 45,200 | +100.0% | 0.04% | – |
| CABA | CABALETTA BIO INC | $1,760,000 | -68.8% | 464,252 | 0.0% | 0.04% | -66.4% | |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $1,735,000 | -89.0% | 552,690 | -82.8% | 0.04% | -88.3% |
| MDVL | MEDAVAIL HOLDINGS INC | $1,600,000 | -52.0% | 1,142,552 | 0.0% | 0.03% | -47.7% | |
| BFLYWS | BUTTERFLY NETWORK INC*w exp 02/12/202 | $931,000 | -53.8% | 733,333 | 0.0% | 0.02% | -48.7% | |
| CMAXW | CAREMAX INC*w exp 06/08/202 | $941,000 | -50.5% | 672,000 | 0.0% | 0.02% | -45.9% | |
| New | THE ONCOLOGY INSTITUTE INC*w exp 11/15/202 | $863,000 | – | 1,250,000 | +100.0% | 0.02% | – | |
| QSIAW | QUANTUM SI INC*w exp 06/10/202 | $600,000 | -11.4% | 333,333 | 0.0% | 0.01% | 0.0% | |
| SOMALOGIC INC*w exp 08/31/202 | $401,000 | -3.1% | 120,000 | 0.0% | 0.01% | 0.0% | ||
| NUVBWS | NUVATION BIO INC*w exp 07/07/202 | $315,000 | -26.2% | 166,666 | 0.0% | 0.01% | -12.5% | |
| SNRHW | SENIOR CONNECT ACQUISITN COR*w exp 12/31/202 | $263,000 | -25.9% | 500,000 | 0.0% | 0.01% | -14.3% | |
| IGNYW | IGNYTE ACQUISITION CORP*w exp 01/05/202 | $279,000 | +20.3% | 362,500 | 0.0% | 0.01% | +20.0% | |
| SURROZEN INC*w exp 08/01/203 | $192,000 | +1.1% | 166,666 | 0.0% | 0.00% | 0.0% | ||
| TMPMW | New | TURMERIC ACQUISITION CORP*w exp 10/08/202 | $170,000 | – | 250,000 | +100.0% | 0.00% | – |
| EUCRW | New | EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202 | $193,000 | – | 333,333 | +100.0% | 0.00% | – |
| MTACW | MEDTECH ACQUISITION CORP*w exp 12/22/202 | $174,000 | -36.3% | 333,333 | 0.0% | 0.00% | -20.0% | |
| REVHW | REVOLUTION HEALTHCAR AQ CORP*w exp 12/31/202 | $150,000 | -19.4% | 200,000 | 0.0% | 0.00% | -25.0% | |
| BDSI | Sell | BIODELIVERY SCIENCES INTL IN | $91,000 | -99.7% | 29,204 | -99.7% | 0.00% | -99.7% |
| OHPAW | ORION ACQUISITION CORP*w exp 02/19/202 | $81,000 | +1.2% | 125,000 | 0.0% | 0.00% | 0.0% | |
| WINT | WINDTREE THERAPEUTICS INC | $32,000 | -23.8% | 20,148 | 0.0% | 0.00% | 0.0% | |
| MTCR | Exit | METACRINE INC | $0 | – | -277,469 | -100.0% | -0.02% | – |
| MAACW | Exit | MONTES ARCHIMEDES ACQUISITIO*w exp 99/99/999 | $0 | – | -1,000,000 | -100.0% | -0.03% | – |
| DFPHW | Exit | DFP HEALTHCARE ACQUISITNS CO*w exp 03/31/202 | $0 | – | -1,250,000 | -100.0% | -0.04% | – |
| TALK | Exit | TALKSPACE INC | $0 | – | -750,000 | -100.0% | -0.05% | – |
| IRTC | Exit | IRHYTHM TECHNOLOGIES INC | $0 | – | -60,271 | -100.0% | -0.07% | – |
| TPTX | Exit | TURNING POINT THERAPEUTICS I | $0 | – | -83,846 | -100.0% | -0.11% | – |
| Exit | BENEFITFOCUS INCnote 1.250%12/1 | $0 | – | -6,500,000 | -100.0% | -0.12% | – | |
| RPHM | Exit | RENEO PHARMACEUTICALS INC | $0 | – | -849,300 | -100.0% | -0.12% | – |
| BDTX | Exit | BLACK DIAMOND THERAPEUTICS I | $0 | – | -760,128 | -100.0% | -0.13% | – |
| CVRX | Exit | CVRX INC | $0 | – | -413,747 | -100.0% | -0.13% | – |
| TMPMU | Exit | TURMERIC ACQUISITION CORPunit 10/08/2025 | $0 | – | -750,000 | -100.0% | -0.14% | – |
| OLMA | Exit | OLEMA PHARMACEUTICALS INC | $0 | – | -271,191 | -100.0% | -0.15% | – |
| AVAH | Exit | AVEANNA HEALTHCARE HLDGS INC | $0 | – | -1,013,007 | -100.0% | -0.16% | – |
| GHRS | Exit | GH RESEARCH PLCordinary shares | $0 | – | -405,416 | -100.0% | -0.18% | – |
| Exit | CUE HEALTH INC | $0 | – | -798,867 | -100.0% | -0.18% | – | |
| AUPH | Exit | AURINIA PHARMACEUTICALS INCput | $0 | – | -425,300 | -100.0% | -0.18% | – |
| SRSAU | Exit | SARISSA CAPITAL ACQUISITN COunit 10/23/2027 | $0 | – | -1,000,000 | -100.0% | -0.19% | – |
| EUCRU | Exit | EUCRATES BIOMEDICAL ACQU CORunit 10/23/2027 | $0 | – | -1,000,000 | -100.0% | -0.19% | – |
| Exit | TYRA BIOSCIENCES INC | $0 | – | -625,000 | -100.0% | -0.22% | – | |
| Exit | RXSIGHT INC | $0 | – | -900,000 | -100.0% | -0.22% | – | |
| SPRB | Exit | SPRUCE BIOSCIENCES INC | $0 | – | -2,200,000 | -100.0% | -0.26% | – |
| GRPH | Exit | GRAPHITE BIO INC | $0 | – | -906,308 | -100.0% | -0.29% | – |
| AVTE | Exit | AEROVATE THERAPEUTICS INC | $0 | – | -714,285 | -100.0% | -0.29% | – |
| LPTX | Exit | LEAP THERAPEUTICS INC | $0 | – | -4,000,000 | -100.0% | -0.31% | – |
| Exit | ERASCA INC | $0 | – | -786,660 | -100.0% | -0.33% | – | |
| MAAC | Exit | MONTES ARCHIMEDES ACQUISITIO | $0 | – | -2,000,000 | -100.0% | -0.36% | – |
| TIL | Exit | INSTIL BIO INC | $0 | – | -1,115,739 | -100.0% | -0.39% | – |
| ITMR | Exit | ITAMAR MED LTDsponsored ads | $0 | – | -694,667 | -100.0% | -0.41% | – |
| FATE | Exit | FATE THERAPEUTICS INC | $0 | – | -362,000 | -100.0% | -0.42% | – |
| XLRN | Exit | ACCELERON PHARMA INC | $0 | – | -145,000 | -100.0% | -0.49% | – |
| DFPH | Exit | DFP HEALTHCARE ACQUISITNS CO | $0 | – | -5,000,000 | -100.0% | -0.97% | – |
| Exit | INSMED INCnote 0.750% 6/0 | $0 | – | -50,000,000 | -100.0% | -1.08% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
| 13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.